Sep
18
The case for R&D observability
Why is it so hard to get answers to pretty straightforward questions, when it comes to biotech data? And what
4 min read
Latest
Aug
19
Breaking the “me too” drug cycle in biotech
A significant limitation of AI-driven biotech has been the training data. With so many models drawing on the same pool
4 min read
Aug
07
Productivity is never linear
Cutting out two hours often means saving two weeks. Below, we cover why productivity gains can be such a powerful
4 min read
Jul
16
Every day counts in biotech R&D
When I was seven years old, my mom was diagnosed with leukemia. We were a freshly immigrated family, still figuring
3 min read
Jul
01
What your biotech engineering team should never build
As a biotech company, every resource - minute, dollar, and FTE focus - counts in your race to reach market.
5 min read
Jun
09
Driving commercial success in biopharma: in conversation with Paul Sekhri
What does it take to effectively commercialize a drug? How can biotech leaders successfully navigate this long, winding, and expensive
4 min read
Jun
04
Biotech markets are down. So what?
The most misguided assumption in biotech investing right now is that tough markets hurt everyone equally.
We've been
4 min read
May
22
How CROs reshaped biotech and why it matters today
Biotech today runs on an interconnected web of partners: CROs, CDMOs, academic labs, and startup biotechs all working in tandem.
5 min read
May
07
What biotechs can learn about outsourcing work
CROs, CDMOs, and other external parties are crucial pieces of the Life Science commercialization puzzle. But while biotech has embraced
6 min read
Apr
17
The Accidental Operator
Last month, we wrote about why operational roles matter more in biotech than people think. The response was fantastic – it
5 min read